Immunotherapeutics (M.Sc)

Overview

Due to oversubscription on this programme, no further applications will be taken to the MSc in Immunotherapeutics for 2023/2024 from Wednesday 26th April next.  Applications will open up again for 2024/25 later in the year

Course Overview

This one-year Masters course in ImmunoTherapeutics is an innovative and multidisciplinary postgraduate degree taught by leading academics in the field of Immunology.

Students will learn about the immune system in cancer, autoimmunity, infection and neurodegeneration and how cutting-edge immunotherapies are revolutionising the treatment of life-threatening and debilitating diseases. This course also includes the study of the exciting technologies of DNA/RNA vaccines, antibody, stem cell and CAR T-cell therapies, as well as immune-checkpoint blockade.

Additionally, skills in business development, innovation, entrepreneurship and communication will be taught in the Trinity Business School and bioprocessing in the National Institute for Bioprocessing, Research and Training (NIBRT) at their state-of-the-art facility.

A key component of the course is the 6-month industry placement to be completed by each student in collaboration with an academic staff member.

Is This Course For Me?

The M.Sc. in Immunotherapeutics is open to scientific, medical, dentistry, veterinary and engineering graduates who wish to obtain in-depth knowledge of ImmunoTherapeutics, fundamental immunology and the advanced technologies that underpin immunotherapeutic development. This M.Sc. programme is particularly suitable for graduates who wish to work in high-level jobs in the Biopharma industry or continue further academic research.

Career Opportunities

To date, graduates of the MSc programme in ImmunoTherapeutics have a 100 % employment rate in careers such as R&D, communications, sales, marketing and regulatory affairs. The School of Biochemistry & Immunology is at the forefront of immunological research worldwide, with Clarivate analytics describing three Trinity immunologists in the top 1% of researchers worldwide based on number of citations.

The M.Sc. in ImmunoTherapeutics has a strong industry and entrepreneurial focus and is designed to provide graduates with analytical, innovation, communication and teamwork skills required for a successful career in the Immunotherapeutic/Biopharma industry or further academic research.

This Masters has been designed in collaboration with the Biopharma industry in Ireland. Industry partners committed to teaching and project placements include Avectas Ltd, Pfizer, Janssen Pharmaceutica, Fountain Healthcare, NIBRT, GlaxoSmithKline, Iontas Antibody Discovery, Galactica Biotech, Merrion Fertility, HiTech Health and Solvotrin.

The world’s top 10 largest biopharma companies operate in Ireland with employment in this sector growing fivefold over the last 30 years.

Course Content

The following modules are mandatory and make up the taught components of the course:

- Fundamental Immunology

- Bioprocessing

- Advanced ImmunoTechnologies

- Entrepreneurial Action

- ImmunoTherapeutics

- Computational Immunology

- Research in Action

- Innovation and Drug Development

In addition, this M.Sc. programme provides a 6-month placement within the industry, in collaboration with an academic member of staff. A dissertation will be prepared and submitted for assessment.

Click Here for further information on modules/subject.

Course Structure
Students take modules totalling 90 ECTS, which consist of 60 ECTS taught modules and a 30 ECTS project placement and dissertation. Students will partake in a 6-month project placement in a relevant industry in collaboration with an academic member of staff.